Underweight: Tiered 10-15% trim now at $57.82, second tranche on bounce to $59-60, hard stop $56.80
Underweight at 85-90% of benchmark weight—initial 10-15% trim at $57.82, second 10-15% trim on bounce to $59-60, hard stop $56.80, mandatory -1.0%/5-session alpha-loss trim trigger, Q3 2026 earnings as binary re-evaluation. Synthesis addresses deterioration thesis (earnings quality collapse, multi-tier technical breakdown, hostile macro) without repeating silent bleed (Hold) or premature-exit (full Sell) patterns. Brand quality, 3.6% dividend carry, and 200 SMA structural floor defense (held 42+ sessions) argue against full exit while deterioration cluster argues against passive Hold. Trader's 25-40% trim rejected for internal inconsistency (stop at $62.00 above $59.50 entry) and overcommitment on directional side.
| Position | Action |
|---|---|
| 85-90% of consumer staples benchmark weight | Modest 10-15% reduction from benchmark |
| Current levels $57.80-58.00 | Market orders for initial 10-15% trim (Tier 1) |
| Bounce to $59.50-60.00 (50 SMA / 10 EMA / prior breakdown level) | Limit sells for second 10-15% trim (Tier 2) |
| Confirmed weekly close below $56.80 on volume ≥10M | Further downgrade to Sell; trim residual aggressively toward 50% of benchmark |
| Close >$62.06 (50 SMA) on volume ≥10M with MACD histogram positive AND RSI >50 | Re-engagement trigger (upgrade to Hold/Overweight) |
MDLZ is a high-quality defensive compounder with 3.6% dividend yield, 0.40 beta, and ~40% emerging market exposure that is being unfairly punished by macro-driven rate sensitivity rather than company-specific deterioration, creating a lopsided risk/reward with limited downside and 17-24% upside to fair value.
| Indicator | Value | Signal |
|---|---|---|
| Close | $57.82 | bearish |
| 10 EMA | $59.74 | bearish |
| 50 SMA | $61.49 | bearish |
| 200 SMA | $58.51 | bearish |
| RSI (14-day) | 30.51 | neutral |
| MACD | -0.74 | bearish |
| MACD Signal | -0.42 | bearish |
| MACD Histogram | -0.32 | bearish |
| Bollinger Middle | $60.74 | neutral |
| Bollinger Lower | $58.43 | bearish |
| Bollinger Upper | $63.04 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Pullback to $53.40-$54.00 zone with RSI divergence and capitulation volume (RSI <30, MACD histogram compressing toward zero)
Then: Defensive add-on with stop at $51.00
RSI at 30.5 is oversold and historically a fertile buying zone for low-beta high-quality names, not a bearish signal
↩ rebuts: “Bear's RSI argument that RSI at 30.5 with no bullish divergence is a red flag”
EV: $68-72 (20-21x forward EPS of $3.36) · concedes: Bear's technical caution is intellectually defensible over a 2-week window; Legitimate risk of $57 break opening up $55 (~5% additional decline)
MDLZ at $57.82 is a slow-motion value trap, not a quality compounder at a discount, due to technical breakdown, misleading earnings, fragile balance sheet, and hostile macro conditions.
EV: $50-52 (3-6 month target, 12-14% downside from $57.82) · concedes: The bull is correct that Q3 earnings could surprise if EM volumes hold and cocoa costs stay normalized; The dividend yield of 3.6% is real and has been consistently paid; MDLZ does have strong brands (Oreos, Cadbury) with global recognition; At $48-50, the multiple would be more reasonable and could represent a better entry
→ vs conservative: Earnings quality thesis cannot be dismissed; Q1 2026 EPS of $1.20 is an anomaly, underlying earnings are $0.55-$0.65, making the 17.2x forward P/E a fiction and the 24-25x actual multiple not a defensive staple valuation
→ vs conservative: PEG of 0.86 is artificially cheap because the G in the denominator is inflated by the anomalous EPS; the cheap-looking multiple is a trap
→ vs conservative: Dividend yield of 3.6% is not a safety net; 112% FCF payout ratio means dividends are covered by debt issuance, creating a deferred capital structure problem in a higher-for-longer environment
→ vs conservative: Wait-for-weekly-close-above-200SMA is being wrong slowly; the data is already here
→ vs conservative: Quiet news flow and falling recession odds (8%) miss the point; 10-year Treasury at highest since 2002 and 97% probability of no 2026 rate cuts create hostile macro for bond-proxy defensives
→ vs neutral: Technical picture is structural breakdown, not consolidation; loss of 50 SMA, 10 EMA, and 200 SMA in rapid succession is a rolling over pattern, not a bounce setup
→ vs neutral: RSI at 30.5 with no bullish divergence (lower lows in both price and RSI) contradicts mean reversion thesis; in strong downtrends RSI stays oversold for extended periods
→ vs neutral: Close below lower Bollinger Band is not a reliable mean reversion signal here; no confirmation of a bottom exists
→ vs neutral: Macro backdrop is not mixed; direction of travel is higher real yields, stronger dollar, and multiple compression for high-quality defensives
→ vs neutral: Waiting for more data means giving back another 3-5% before capitulation; trim into $59-$60 strength is the right timing to exit a broken name
| neutral |
| ATR | $1.20 | neutral |
| Volume (09-30) | 10.97M shares | neutral |
Support: 58.51 · 57 · 55 | Resistance: 59.74 · 60.74 · 61.49
MDLZ is in a confirmed short-term downtrend after breaking below all key moving averages, with the 200-day SMA at $58.51 representing the critical long-term support level to reclaim for stabilization. Technical indicators show oversold conditions (RSI 30.51, close below Bollinger Lower Band) with compressing ATR ($1.20) suggesting volatility stabilization, but bearish momentum continues with MACD histogram widening to -0.32 and no bullish RSI divergence. The final recommendation is HOLD: existing investors should monitor $57.00 support closely, while new longs await either a confirmed reversal pattern with volume in the $57-$58 zone or a full trend reset above the 50 SMA.
Market Cap
$73.72 B
PE Ratio (TTM)
21.16
Forward PE
17.18
PEG Ratio
0.86
Price / Book
2.78
EPS (TTM)
$2.73
Forward EPS
$3.36
Dividend Yield
3.60%
Beta
0.40
52-Week High
$66.65
52-Week Low
$51.20
Book Value
$20.80
Revenue (TTM)
$39.67 B
Gross Profit (TTM)
$12.36 B
Gross Margin (TTM)
31.1%
Operating Margin (TTM)
21.98%
Net Profit Margin (TTM)
8.86%
EBITDA (TTM)
$6.08 B
Net Income (TTM)
$3.52 B
ROE
13.34%
ROA
4.12%
Total Assets
$71.12 B
Total Equity
$25.75 B
Total Debt
$21.62 B
Net Debt
$19.50 B
Debt / Equity
0.84
Current Ratio
0.60
Working Capital
-$10.76 B
Long-Term Debt
$15.47 B
Short-Term Debt
$5.56 B
FCF (TTM)
$2.25 B
Dividends Annualized
~$2.55 B
Buybacks (TTM)
~$0.86 B
Goodwill & Intangibles
$43.8 B
Tangible Book Value
-$18.0 B
Net Debt / EBITDA
~3.2x
Interest Expense
~$600M annually
Q1 2026 Revenue YoY Growth
+8.2%
Strengths
Concerns
MDLZ is a global snack and confectionery leader (Oreo, Cadbury, Milka) with strong emerging market exposure (~40% of revenue) and defensive characteristics (beta 0.40). The company trades at a reasonable valuation with a PEG of 0.86 and Forward PE of 17.18x, offering a 3.6% dividend yield well-supported by $2.25B TTM free cash flow. Key risks include elevated leverage (Net Debt $19.5B), cocoa cost volatility, and negative tangible book value, though improving top-line growth (+8.2% YoY in Q1 2026) and the rate-cut environment should benefit earnings recovery.
Macro: Hawkish macro repricing is the dominant theme. The 10-Year Treasury yield touched its highest level since 2002 with September 2026 posting the biggest monthly gain since 2022. Markets price zero Fed rate cuts in 2026 at 97% probability while recession odds are falling (US: 8%, down 2pp wk-over-week). This creates a soft-landing-with-tight-policy regime—constructive for staples' earnings stability but negative for multiple expansion as elevated yields cap valuation. USD bias remains strong due to higher real yields, creating FX headwinds for MDLZ's ~70% non-US revenue base. AI/tech growth names are leading equity markets while defensive consumer staples are lagging.